Showing 34,857 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

The search for a cure

Gene therapy decreases HIV reservoir and moderately suppresses viral load in some

News
4 April 2023
Undetectable viral load & treatment as prevention

What does undetectable = untransmittable (U=U) mean?

About HIV
April 2023
HIV testing programmes & uptake

Late HIV diagnosis still an issue in Aotearoa

Editor's pick
Medical Xpress
3 April 2023
HIV & criminal law

U=U acknowledged in prosecutors’ guidance in England and Wales

News
3 April 2023
How HIV works

HIV can persist for years in myeloid cells of people on antiretroviral therapy

Editor's pick
National Institutes of Health
31 March 2023
Harm reduction

FDA Approves First Over-the-Counter Naloxone Product

Editor's pick
Filter
31 March 2023
Access to healthcare

Religious “Freedom” Laws Are Trying to Drag Us Back to the Height of the AIDS Epidemic

Editor's pick
TheBody
31 March 2023
Mpox (monkeypox)

US tops 1 million mpox vaccine doses given, but coverage lags in risk groups

Editor's pick
CIDRAP
31 March 2023
HIV & criminal law

HIV, sex and the law

About HIV
March 2023
Injectable & long-acting PrEP

Pharmaceutical corporation ViiV must provide transparency on life-saving HIV-prevention drug

Editor's pick
Médecins Sans Frontières
31 March 2023
Health services & systems

Decolonising global health: lessons from Zimbabwe

News
31 March 2023
Confidentiality, consent & medical ethics

NHS Highland: Personal info of likely HIV patients leaked

Editor's pick
HeraldScotland
30 March 2023
Migrants, refugees & displaced people

UK: Illegal Migration Bill could be ‘death sentence’ for people on HIV/AIDS medication, MPs warn

Editor's pick
Pink News
30 March 2023
Injectable & long-acting HIV treatment

Clinic finds almost half of people who want long-acting HIV treatment don’t initiate it

Editor's pick
CATIE
30 March 2023
PrEP policies & guidelines

Texas judge strikes down major Obamacare provision protecting birth control, PrEP coverage

Editor's pick
STAT
30 March 2023
HIV & criminal law

Uganda’s anti-gay bill will criminalize HIV programs, activists warn

Editor's pick
Devex News
30 March 2023
Combatting stigma

Paul O'Grady: How Lily Savage defied police who raided a pub with rubber gloves

Editor's pick
BBC News
30 March 2023
Injectable & long-acting PrEP

Medicines Patent Pool signs sublicences with Aurobindo, Cipla and Viatris to produce generic versions of ViiV Healthcare’s innovative long-acting HIV prevention medicine

Editor's pick
Medicines Patent Pool
30 March 2023
Cancer

Frequent screening will be essential to eliminate cervical cancer in women with HIV

News
30 March 2023
Injectable & long-acting PrEP

Cabotegravir long-acting for PrEP registrations continue in Sub-Saharan Africa

Editor's pick
ViiV press release
29 March 2023
Ageing & HIV

Another survey with HIV long-term survivors. Have we learned anything new?

Editor's pick
San Francisco AIDS Foundation
29 March 2023
HIV in the arts & media

HIV Advocacy on Tik Tok

Editor's pick
POZ
29 March 2023
History of HIV & AIDS

Ward 86 at 40

Editor's pick
POZ
29 March 2023
Global health targets

Africa's TB reduction rate falls short amid slowing global progress

Editor's pick
World Health Organization
29 March 2023